BioSpace News Archive

GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company or the Group), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, along with U.S. subsidiary Greenwich Biosciences, announced today that JAMA Neurology has published results of the company’s positive Phase 3 clinical trial of EPIDIOLEX ® (cannabidiol) oral solution in seizures associated with tuberous sclerosis complex (TSC). EPIDI

Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO:SOBI ) has appointed Duane Barnes as the new Head of Sobi in North America . “Sobi in North America has gone through significant change over the past few years and has exciting launches both underway and coming up in the years ahead,” says Guido Oelkers , CEO and President of S

Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced that abstracts detailing new interim results from its ABO-102 Phase 1/2 Transpher A study for MPS IIIA and ABO-101 Phase 1/2 Transpher B study for MPS IIIB have been accepted for platform oral presentations during the late-breaking abstract session at the 17 th Annual WORLD Symposium ™ being held February 8-12, 2021. “Children

Concert Genetics today unveiled the Concert Genetics Benefit Program, an end-to-end genetic testing management solution that enables health plans to provide members with access to high-quality, clinically appropriate genetic testing while improving payment integrity and reducing manual work.

The Somatic Experiencing ® Trauma Institute (SE Institute) and Therapy Aid Coalition (TAC) today announced that the two organizations are collaborating to provide meaningful mental health and wellness resources to frontline workers and emergency responders affected by the coronavirus pandemic

Abivax (Euronext Paris: FR0012333284 - ABVX), a clinical-stage biotechnology company harnessing the immune system to develop novel treatments for inflammatory diseases, viral diseases and cancer, today announced that Prof. Hartmut J. Ehrlich, M.D., CEO of Abivax, will present at the 39 th Annual J.P. Morgan Healthcare Conference on Thursday,

The Government of Canada is closely monitoring the genetic variant of the virus that causes COVID-19 identified in the United Kingdom and is working with international and other partners including the World Health Organization to better understand this variant and its impacts.

COMIRNATY ® (also known as BNT162b2) receives conditional marketing authorization from the European Commission; this milestone represents a global joint effort to advance the first authorized mRNA vaccine

SCONE Medical Solutions Inc., a Phoenix -based MedTech startup, has pioneered a new strategy for PPE in healthcare facilities, aimed at reducing the risk of aerosol transmission of contagious diseases to healthcare workers (HCWs), other patients, and hospital visitors. The Self-Contained Negative Pressure Environment (SCONE™) is a low-c

Virios Therapeutics, Inc. (Nasdaq: VIRI), a biotechnology company focused on advancing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response, today announced the closing of its initial public offering of 3,450,000 shares of its common stock at a public offering price of $10.00 per share, which includes 450,000 shares sold upon full exercise of the underwriter’s option to purchase